EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review

Jiaoyu Yi, Bo Tao, Hao Chen, Nobuyuki Horita, Yong Xu

Current Molecular Pharmacology · 2026 · 19 (1) · 27-40

DOI: 10.1016/j.cmp.2026.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Jiaoyu Yi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Lingjun Program, National Natural Science Foundation of China, China Academy of Space Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Shanghai Lingjun Program
  • National Natural Science Foundation of China
  • China Academy of Space Technology

Zitieren

APA

Yi, J., Tao, B., Chen, H., Horita, N., & Xu, Y. (2026). The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review. Current Molecular Pharmacology, 19(1), 27-40. https://doi.org/10.1016/j.cmp.2026.03.004

Vancouver

Yi J, Tao B, Chen H, Horita N, Xu Y. The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review. Current Molecular Pharmacology. 2026;19(1):27-40. doi:10.1016/j.cmp.2026.03.004

BibTeX
@article{Yi2026,
  author = {Yi, Jiaoyu and Tao, Bo and Chen, Hao and Horita, Nobuyuki and Xu, Yong},
  title = {The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {27--40},
  doi = {10.1016/j.cmp.2026.03.004}
}
Kostenlos starten →